Hepcidin: New Biomarker for Leptomeningeal Metastases
In a groundbreaking development within oncology and neuro-oncology, researchers have unveiled compelling evidence positioning hepcidin as a potent biomarker for detecting leptomeningeal metastases (LMD) in...
















